The frequency of hip fractures is increasing with our ageing population, with an annual incidence of between 1.4 and 5 per 103 per year ([@CIT0027], [@CIT0016], [@CIT0040]). Health model projections have estimated that 6.3 million hip fractures will occur annually worldwide within the next 40 years ([@CIT0007]), imposing a significant economic health burden. There is a large reported perioperative mortality rate in this population, ranging from 2.4% to 8.2% at 1 month ([@CIT0031], [@CIT0035]) and over 25% at 1 year ([@CIT0009], [@CIT0017]). Furthermore, it was recently reported that the current mortality rate is higher now than 25 years ago ([@CIT0041]). Today, it is generally accepted that displaced intracapsular fractures are best treated with arthroplasty rather than internal fixation ([@CIT0019], [@CIT0025]). In the at-risk population, however, multiple comorbidities are common and the best form of component fixation is in question.

Bone cement implantation syndrome is a well-described complication of cemented hip arthroplasty. It is characterized by a systemic drop in systolic blood pressure, hypoxemia, pulmonary hypertension, cardiac dysrhythmias, and occasionally cardiac arrest and death ([@CIT0037], [@CIT0028], [@CIT0030]). The prevailing theory to explain the pathophysiology of this phenomenon is embolism of fat, marrow contents, bone, and to some degree methylmethacrylate to the lung ([@CIT0037], [@CIT0010], [@CIT0030], [@CIT0023]). An increased degree of pulmonary insult with fat microemboli has been demonstrated (mostly in randomized controlled trials) during insertion of a cemented femoral stem rather than an uncemented implant ([@CIT0028], [@CIT0036], [@CIT0004], [@CIT0034]), presumably due to increased intramedullary femoral canal pressures in the cemented group ([@CIT0018], [@CIT0028]). These pressures can be reduced by the use of distal venting holes in the femur during stem insertion ([@CIT0012]). It has been shown previously by single-institutional review that patients undergoing cemented hip arthroplasty have a higher intraoperative mortality rate relative to uncemented arthroplasty, presumably due to a reduced incidence of fat embolism in the latter group ([@CIT0030]). The increased mortality risk was also present at 30 days in the treatment of acute fractures with cemented arthroplasty, also from a single-institutional review ([@CIT0032]). Although cement-related mortality is rare ([@CIT0008], [@CIT0030], [@CIT0031], [@CIT0032], [@CIT0043]), it is a devastating complication---often reported through observational studies or literature reviews. Proponents of uncemented hip arthroplasty often cite this concern to support their reluctance to use cemented hip arthroplasty in both elective procedures and fracture management. However, many different types of studies have been unable to identify any increased mortality risk with the use of cement ([@CIT0024] (observational), [@CIT0011] (RCT), [@CIT0026] (observational), [@CIT0020],b (literature review), [@CIT0029] (literature review)) and others have shown a decrease in mortality at 30 days when cement is used ([@CIT0013]).

Cemented hip hemiarthroplasty appears to offer improved rate of return to baseline function, reduced postoperative pain, and superior long-term survivorship relative to uncemented arthroplasty ([@CIT0020], [@CIT0021], [@CIT0029]). We reasoned that failure to return to baseline function after hemiarthroplasty may be another risk factor for perioperative mortality ([@CIT0015], [@CIT0003]). Lower revision rates for cemented prostheses and increased mortality at revision surgery contribute further to reducing the overall mortality risk. We evaluated the relationship between the method of fixation of hip arthroplasty and perioperative mortality using a large national joint replacement registry.

Patients and methods {#ss1}
====================

Data pertaining to patient age, implant type, fixation method, and patient location were obtained from the Australian Orthopaedic Association (AOA) National Joint Replacement Registry (NJRR). Mortality information was obtained by patient matching with the National Death Index (NDI) from the Australian Institute of Health and Welfare. The outcome of interest was mortality at 1 day, 1 week, 1 month, and 1 year after surgery. Data were then stratified by implant type to examine the effect of cement fixation within monoblock and modular implant procedures.

The AOA NJRR identified patient selection differences for implant type based on demographic data. As patient comorbidities are not captured in the AOA NJRR, these demographics were used as a surrogate measure for different patient populations in an effort to adjust for bias in the comparison of fixation method. We hypothesized that monoblock components are usually reserved for more elderly, lower-demand patients with more comorbidities and that modular prosthesis implants are used in healthier patients with expected longer survival.

Data in the AOA NJRR are collected at the time of surgery using a standard paper-based form, with methods described in more detail elsewhere ([@CIT0006], [@CIT0001]). Each hospital subsequently forwards these forms to the registry for data entry. Forms with incomplete or inconsistent data are followed up by the registry with the hospital concerned. Cases where forms have not been completed are identified by verification of registry data using government hospitalization separation data.

Statistics {#ss2}
----------

Mortality rates were compared between cemented and uncemented prostheses using a time-dependent Cox proportional-hazards model. For each model, the assumption of proportional hazards was checked analytically by inspecting the graph of log(log(survival)) plotted against log of survival time. Time points were selected a priori based on clinical importance, and hazard ratios were then calculated for each selected time period. All analyses were adjusted for age and sex as measured at the date of the primary procedure. All analyses were performed using SAS software version 9.1.

Ethics {#ss3}
------

Local ethical approval was not required from our institution, as this study was purely data-driven and used de-identified national data. A formal request was made to the Australian Orthopaedic Association (AOA) National Joint Replacement Registry (NJRR) for access to the national de-identified data.

Results {#ss4}
=======

Patient demographics {#ss5}
--------------------

12,804 patients were treated with uncemented hemiarthroplasty and 12,935 were treated with cemented hemiarthroplasty. No statistically significant differences in demographic characteristics between the methods of fixation were detected among the different groups ([Table 1](#T1){ref-type="table"}).

###### 

Patient demographics for hemiarthroplasty procedures

  Type of component   Total                    Age                             \% Females
  ------------------- -------- --------------- --------------- --------------- ------------
  Monoblock                                                                    
   Cemented           3,634    169 (4.7%)      946 (26.0%)     2,519 (69.3%)   74
   Uncemented         10,362   420 (4.1%)      2,550 (24.6%)   7,392 (71.3%)   74
   Subtotal           13,996   589             3,496           9,911           
  Modular                                                                      
   Cemented           9,301    1,518 (16.3%)   3,233 (34.8%)   4,550 (49.6%)   74
   Uncemented         2,442    446 (18.3%)     750 (30.7%)     1,246 (51.0%)   72
   Subtotal           11,743   1,964           3,983           5,796           
  Total               25,739   2,553           7,479           15,707          

Perioperative mortality {#ss6}
-----------------------

Kaplan Meier survival estimates by postoperative days are shown in [Figure 1](#F1){ref-type="fig"} and hazard ratios are detailed in [Table 2](#T2){ref-type="table"}. There was an increased risk of perioperative mortality in patients treated with uncemented hemiarthroplasty at 1 week (p = 0.02), 1 month (p = 0.03), and 1 year (p \< 0.001) postoperatively. Conversely, there was a greater risk of perioperative mortality in the first postoperative day in patients treated with cemented components (p \< 0.001), suggesting that at-risk patients are more likely to succumb early if cement is used. However, most patients receiving cemented components were treated with modular components (9,301 of 12,935; 72%), whereas most patients receiving uncemented components received a monoblock prosthesis (10,362 of 12,804; 81%). We were therefore interested in further characterizing the role of fixation method in different patient groups, to identify the true effect of cement on mortality.

![All-cause mortality in cemented and uncemented hemiarthroplasty patients.](ORT-0300-9734-082-275_g001){#F1}

###### 

Hazard ratios (HRs) for risk of death, according to kind of fixation, for all hemiarthroplasties

            HR (95% CI) (cementless vs. cemented)   p-value    No. of deaths   
  --------- --------------------------------------- ---------- --------------- -------
  1 day     0.59 (0.43--0.79)                       0.0005     109             70
  1 week    1.36 (1.05--1.74)                       0.02       345             384
  1 month   1.27 (1.03--1.58)                       0.03       860             1,170
  1 year    1.37 (1.29--1.49)                       \< 0.001   2,680           3,794

Cemented vs. uncemented monoblock components {#ss7}
--------------------------------------------

10,362 patients were treated with uncemented monoblock implants and 3,634 patients received cemented monoblock implants. The mortality rate was higher at day 1 when cemented monoblock implants were used (p \< 0.001). This has been further detailed---per day for the first postoperative week---in [Table 3](#T3){ref-type="table"}. However, this difference between groups was no longer statistically significant at 1 week or 1 month. By 1 year, the death rate had reversed with a favorable survival for patients treated with cemented implants (p \< 0.001) ([Figure 2](#F2){ref-type="fig"} and [Table 4](#T4){ref-type="table"}).

###### 

Hazard ratios (HRs) for day of operation to day 6 for risk of death, according to kind of fixation, for monoblock hemiarthroplasty

      Cemented   Cementless                                                          
  --- ---------- ------------ ------------------- -------- ----- ------------------- -------------------
  0   3,634      0            100                 10,362   0     100                 
  1   3,582      46           99.3 (99.0--99.6)   10,299   62    99.9 (99.8--99.9)   0.47 (0.32--0.68)
  2   3,557      70           98.7 (98.3--99.0)   10,258   102   99.4 (99.2--99.5)   0.57 (0.35--0.95)
  3   3,540      85           98.1 (97.6--98.5)   10,196   161   99.0 (98.8--99.2)   1.35 (0.76--2.37)
  4   3,524      100          97.7 (97.1--98.1)   10,143   212   98.4 (98.2--98.7)   1.17 (0.66--2.07)
  5   3,508      113          97.2 (96.7--97.7)   10,092   259   98.0 (97.7--98.2)   1.24 (0.67--2.29)
  6   3,497      123          96.9 (96.3--97.4)   10,055   295   97.5 (97.2--97.8)   1.24 (0.61--2.49)

![All-cause mortality for cemented and uncemented monoblock hemiarthroplasty.](ORT-0300-9734-082-275_g002){#F2}

###### 

Hazard ratios (HRs) for risk of death, according to kind of fixation, for monoblock hemiarthroplasty

            HR (95% CI) (cementless vs. cemented)   p-value    No. of deaths   
  --------- --------------------------------------- ---------- --------------- -------
  1 day     0.47 (0.32--0.68)                       \< 0.001   46              62
  1 week    1.16 (0.81--1.66)                       0.4        138             340
  1 month   0.95 (0.71--1.26)                       0.7        359             1,051
  1 year    1.23 (1.13--1.34)                       \< 0.001   1,015           3,413

As comorbidities increase with age, we hypothesized that if cement was a risk factor for perioperative mortality, the relationship would be more evident in the elderly patients treated with cemented hemiarthroplasty. To investigate this relationship, we analyzed this cohort of patients further, stratified by age and according to whether they were treated with cemented or uncemented hemiarthroplasty. Although the numbers were relatively small (see [Table 1](#T1){ref-type="table"}), this analysis showed that elderly patients (\> 70 years old) had a more favorable survivorship at 1 year when cemented monoblocks were compared to uncemented monoblocks ([Figure 3](#F3){ref-type="fig"}) (p = 0.005 (patients 71--80 years old) and p \< 0.001 (patients \> 80 years old)). In the older age group (\> 80), there was a higher 1-day mortality rate when cement was used (p \< 0.001), but the significance of this difference was not apparent by 1 week (p = 0.5) or by 1 month (p = 0.9). The situation was even reversed by 1 year (p \< 0.001), when cemented implants had a more favorable mortality rate.

![All-cause mortality in cemented and uncemented monoblock hemiarthroplasty patients stratified by age.](ORT-0300-9734-082-275_g003){#F3}

Cemented vs. uncemented modular components {#ss8}
------------------------------------------

2,442 patients were treated with uncemented modular components, while 9,301 received cemented implants. There was no statistically significant difference in mortality at any time between the methods of fixation of modular implants ([Table 5](#T5){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}).

###### 

Hazard ratios (HRs) for risk of death, according to kind of fixation, for modular hemiarthroplasty

            HR (95% CI) (cementless vs. cemented)   p-value   No. of deaths   
  --------- --------------------------------------- --------- --------------- -----
  1 day     0.48 (0.23--1.01)                       0.05      63              8
  1 week    1.18 (0.70--7.97)                       0.5       207             44
  1 month   0.91 (0.55--1.49)                       0.7       501             119
  1 year    0.89 (0.78--1.02)                       0.09      1,665           381

![All-cause mortality in patients with cemented and uncemented modular components.](ORT-0300-9734-082-275_g004){#F4}

Discussion {#ss9}
==========

Compared to uncemented procedures, we found reduced mortality at 1 year following a cemented procedure. At the outset of this study, it was our hypothesis that there would be similar mortality rates for cemented and uncemented hemiarthroplasty using a large, nationwide joint registry database. The fact that the data revealed a lower overall mortality rate at later times with cemented monoblock procedures was surprising. Together with the fact that implant survival from the AOA NJRR is increased for cemented implants than for uncemented implants into the medium term (AOA 2009) and the existence of previous work demonstrating improved functional outcome and pain scores with cemented implants ([@CIT0020],[@CIT0021], [@CIT0029]), it is becoming increasingly difficult to justify the continued preference of some surgeons for uncemented implants.

The strength of this study lies in the large numbers that were available for analysis. Due to high data completion rates and stringent data validation protocols by the AOA NJRR, the data are robust and easily lend themselves to this type of analysis.

There are many possible explanations for our findings. Firstly, a weakness of this study is that selection of implant fixation was not randomized. In that regard, other patient factors may have influenced the surgeon\'s decision to avoid cement, which may not have been adequately adjusted for in our analysis. For example, it has been shown that pre-existing cardiac disease is an independent risk factor for cement-related mortality ([@CIT0032]). Other risk factors for increased perioperative mortality with hip fracture include age, sex, and comorbidities ([@CIT0015], [@CIT0017], [@CIT0042], [@CIT0040]). The Australian Orthopaedic Association National Joint Replacement Registry does not collect comorbidity data, and in that regard we could not rule out the possibility that selection bias for fixation method influenced overall patient mortality. Our subcategorization of procedures into modular and monoblock components was an effort to control for this variable with a surrogate measure, as monoblock components are typically used in the frail elderly for quicker surgery and as there is less functional demand on the component postoperatively.

In a separate analysis, we found that there was a favorable survival rate at 1 year in patients aged 71--80 and \> 80 when cemented monoblock implants were used rather than uncemented monoblock components. The reasons for this are unclear, but they may relate to selection of fixation method based on patient variables not captured by the AOA NJRR. For example, it is possible that elderly patients receiving cemented monoblock components are generally in better health than those treated with uncemented monoblock hemiarthroplasty, and are felt to be less likely to succumb to cement-related drop in systolic blood pressure intraoperatively. Alternatively, the opposite may be true---as for hip prostheses, generally fitter (younger, healthier) individuals receive cementless prostheses. There is also considerable state-to-state variability in preference for fixation method (AOA 2009), and individual hospital trends, which probably reflect different training and philosophies across the country. Further subanalysis of the relationship of these variables makes broad conclusions difficult, as patient numbers decrease with further subcategorization.

The cause of death was also not investigated in this study; thus, we could not directly link mortality to surgery-related issues. Certainly, 1-day and 1-week mortality are likely to be associated with perioperative factors. Consistent with our study, [@CIT0013]) found a higher 30-day mortality rate in uncemented (9%) vs. cemented (1%) hemiarthroplasties in a retrospective review of 244 patients, despite similar ASA grades in both groups.

[@CIT0029] published a meta-analysis on the outcome of cemented hip arthroplasties vs. uncemented components for hip fracture, and found that mobility and pain at 1 year postoperatively was better in the cemented group. There was no difference in perioperative mortality in their analysis. This report included over 1,900 patients, although still substantially smaller than our study. The same findings were corroborated in a separate meta-analysis of 18 publications comparing cemented and uncemented arthroplasty for hip fractures ([@CIT0021]). Khan\'s group further compared 121 uncemented to 123 cemented Austin-Moore hemiarthroplasty patients done in 2 hospitals ([@CIT0020]). Patients treated with uncemented Austin-Moore implants had more pain, worse function in terms of walking and dependence on walking aids, and reduced capacity to perform activities of daily living compared to patients with cement fixation. There was no statistically significant difference in mortality or non-fatal medical complication rates related to type of fixation used. There were more intraoperative fractures (3/121 uncemented vs. 0/123 cemented), more dislocations (3/121 vs. 0/123), and a higher failure rate (numbers not reported) in patients with uncemented implants. In a single-institution audit, [@CIT0039] reported a higher overall reoperation and revision rate using uncemented Austin-Moore implants than when using cemented Thompson hemiarthroplasties. Patients treated with cemented implants also had a higher overall satisfaction rate relative to those with the uncemented stem. In a small, randomized study comparing cemented Thompson implants to uncemented Austin-Moore implants ([@CIT0011]), pain and dependence on walking aids was less if the femoral component was fixed with cement. There was no difference in mortality or perioperative complications in either group. In a retrospective review of 107 patients treated with Thompson hemiarthroplasty for displaced femoral neck fractures, [@CIT0038] failed to demonstrate any increased rate of mortality, myocardial infarction, cerebrovascular incident, cardiac failure, or postoperative hypotension whether or not cement was used. Similar findings have been reported with other comparisons of cemented and uncemented implants ([@CIT0024], [@CIT0026]).

Although pulmonary fat embolization is much less common with uncemented components, embolic events do occur ([@CIT0028], [@CIT0036], [@CIT0034]), and this is probably related to increased intramedullary pressures during instrumentation of the femoral canal ([@CIT0018], [@CIT0028]). [@CIT0044]) showed that reaming of the intramedullary canal produces pressures averaging 835 mmHg, and that only 200 mmHg is required for fat intravasation and embolization. This compares with maximum pressures of approximately 846 mmHg, demonstrated with introduction of cement into the femoral canal in a dog model by [@CIT0028]). In fact, there have been a few case reports outlining perioperative fat embolism syndrome and mortality due to fat embolization with uncemented hip arthroplasty ([@CIT0002], [@CIT0014]). It is also known that intraoperative complications are higher with uncemented hemiarthroplasty, including iatrogenic femoral fracture ([@CIT0013], [@CIT0043]). A randomized, controlled trial investigating the prevalence of fat and bone marrow emboli in the lung based on right-atrium blood sampling showed similar prevalences with cemented and uncemented components ([@CIT0022]). Furthermore, it has been shown that proper femoral canal lavage and vacuum suction reduce embolic events with cement implantation ([@CIT0005], [@CIT0033]). Modern cement techniques may therefore account for the lower incidence of perioperative mortality with use of cement compared to earlier studies.

In conclusion, this study shows a small but statistically significantly increased risk of mortality at 1 day when cement is used for monoblock hemiarthroplasty procedures. By 1 week, there is no longer a mortality advantage to avoiding cement, and by 1 year, mortality is less when cement is used. This may be due to a higher overall revision rate with uncemented monoblock components. When modular components are compared, there is no difference in mortality at any time analyzed, although there is a higher implant revision rate when uncemented components are used. These data support the use of cemented hemiarthroplasty components in patients with hip fracture.
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